Michael Bronze to HIV Infections
This is a "connection" page, showing publications Michael Bronze has written about HIV Infections.
Connection Strength
1.395
-
Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol. J Virol Methods. 2013 Dec; 194(1-2):300-7.
Score: 0.374
-
Refractory hypoxia in an HIV-infected patient--a diagnostic challenge. Am J Emerg Med. 2012 Sep; 30(7):1322.e5-6.
Score: 0.326
-
Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis. 2000 Dec; 31(6):1488-92.
Score: 0.155
-
False-positive enzyme immunoassay for human immunodeficiency virus due to acute cytomegalovirus infection. Clin Infect Dis. 1998 Jul; 27(1):221-2.
Score: 0.131
-
Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa. J Infect Dis. 2016 Dec 15; 214(12):1826-1830.
Score: 0.116
-
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219.
Score: 0.116
-
Case report: Candida zeylanoides infective endocarditis complicating infection with the human immunodeficiency virus. Am J Med Sci. 1996 Sep; 312(3):138-9.
Score: 0.115
-
Part XV. Antiretroviral therapy for human immunodeficiency virus infection. J Okla State Med Assoc. 2007 Nov; 100(11):417-24.
Score: 0.062